Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, Padova, Italy.
London School of Hygiene and Tropical Medicine, London, United Kingdom.
Environ Res. 2024 Feb 1;242:117743. doi: 10.1016/j.envres.2023.117743. Epub 2023 Nov 25.
Per- and polyfluoroalkyl substances (PFAS) constitute a heterogeneous group of synthetic compounds widely used in industrial applications. The estimation of PFAS half-life (t) is essential to quantify their persistence, their toxicity and mechanism of action in humans.
The purpose of this review is to summarize the evidence on PFAS half-lives in humans from the available literature, and to investigate the limitations and uncertainties characterizing half-life estimation.
The search was conducted on PubMed, Scopus, and Embase databases up to July 03, 2023 and was aimed at identifying all papers that estimated PFAS half-life in human populations. We excluded studies on temporal trends or providing estimates of half-life based solely on renal clearance. As persistent and ongoing exposures can influence half-life estimation, we decided to include only studies that were conducted after the main source of exposure to PFAS had ceased. A random-effects meta-analysis was conducted on studies that reported perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS) or perfluorohexanesulfonic acid (PFHxS) half-life estimation. Risk of bias was evaluated using the OHAT tool.
A total of 13 articles were included in the review, with 5 studies conducted in exposed general populations and 8 studies conducted in exposed workers; the estimated mean half-life ranged from 1.48 to 5.1 years for PFOA, from 3.4 to 5.7 years for total PFOS, and from 2.84 to 8.5 years for PFHxS. High heterogeneity among studies was observed; potential reasons include the variability among the investigated populations, discrepancies in considering ongoing exposures, variability in PFAS isomeric compositions, accounting for background exposure, time since exposure stopped and methods used for half-life estimation.
Despite the efforts made to better understand PFAS toxicokinetics, further studies are needed to identify important characteristics of these persistent chemicals. Biomonitoring studies should focus on persistent and unaccounted sources of exposure to PFAS and on individual characteristics potentially determining half-life, to ensure accurate estimates.
全氟和多氟烷基物质(PFAS)是一组广泛应用于工业应用的合成化合物。PFAS 半衰期(t)的估计对于量化它们在人类中的持久性、毒性和作用机制至关重要。
本综述的目的是总结现有文献中关于人类 PFAS 半衰期的证据,并探讨半衰期估计的局限性和不确定性。
我们在 PubMed、Scopus 和 Embase 数据库中进行了搜索,截至 2023 年 7 月 3 日,旨在确定所有估计人类人群中 PFAS 半衰期的论文。我们排除了仅基于肾清除率提供半衰期估计的研究。由于持续和持续的暴露可能会影响半衰期的估计,因此我们决定仅包括在 PFAS 的主要暴露源停止后进行的研究。对报告全氟辛酸(PFOA)、全氟辛烷磺酸(PFOS)或全氟己烷磺酸(PFHxS)半衰期估计的研究进行了随机效应荟萃分析。使用 OHAT 工具评估偏倚风险。
本综述共纳入 13 篇文章,其中 5 项研究在暴露于普通人群中进行,8 项研究在暴露于工人中进行;PFOA 的估计平均半衰期范围为 1.48 至 5.1 年,总 PFOS 的半衰期范围为 3.4 至 5.7 年,PFHxS 的半衰期范围为 2.84 至 8.5 年。研究之间存在高度异质性;潜在原因包括所研究人群的变异性、对持续暴露的考虑差异、PFAS 同分异构体组成的变异性、背景暴露的核算、暴露停止后的时间以及半衰期估计方法的差异。
尽管为更好地了解 PFAS 毒代动力学做出了努力,但仍需要进一步的研究来确定这些持久性化学物质的重要特征。生物监测研究应侧重于 PFAS 的持久性和未被发现的暴露源,以及可能决定半衰期的个体特征,以确保准确的估计。